Eurofins Scient (OTCMKTS:ERFSF) Sees Strong Trading Volume – Still a Buy?

Eurofins Scient (OTCMKTS:ERFSF – Get Free Report) shares saw unusually-high trading volume on Tuesday. Approximately 36,380 shares changed hands during mid-day trading, an increase of 849% from the average daily volume of 3,835 shares. The stock last traded at $95.7901 and had previously closed at $96.1580.

Analyst Ratings Changes

Separately, Sanford C. Bernstein downgraded Eurofins Scient from an “outperform” rating to a “hold” rating in a report on Tuesday, September 29th. One analyst has rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Hold”.

View Our Latest Analysis on Eurofins Scient

Eurofins Scient Trading Up 0.2%

The company has a quick ratio of 1.07, a current ratio of 1.13 and a debt-to-equity ratio of 0.80. The company has a 50-day simple moving average of $88.42 and a two-hundred day simple moving average of $79.73.

Eurofins Scient Company Profile

(Get Free Report)

Eurofins Scientific SE is a Luxembourg-based international laboratory and testing services company. It provides analytical, inspection and certification services for the pharmaceutical, food, environmental, agricultural, consumer products and healthcare industries.

The company’s services include laboratory testing, product safety and quality analysis, environmental monitoring, pharmaceutical development and validation, genomic testing, clinical diagnostics, and agroscience services. Eurofins also supports companies and public-sector organizations with research, regulatory compliance and quality-control programs.

Founded in 1987 by Gilles Martin, Eurofins has expanded from its original focus on food testing into a broad network of laboratories and specialized testing businesses serving customers in Europe, North America, Asia-Pacific and other international markets.

Featured Articles

Receive News & Ratings for Eurofins Scient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eurofins Scient and related companies with MarketBeat.com's FREE daily email newsletter.